Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

BBNXBBNX
5 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in BETA BIONICS INC

Yes. Point72 Asset Management holds 2,254,683 shares of BBNX (Beta Bionics), worth $35.3M, as of its Q2 2026 13F filing. It reduced the position by 270,357 shares (-10.7%) from Q1 2026. Point72 Asset Management has held BBNX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$35.3M

Current Shares

2.3M

Total Value Change

+$30.9M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-10.7%
$35.3M0.0%$15.67
0
2026-Q1
Increased
2.5M
+155.7%
$25.3M0.0%$11.57
46
2025-Q4
New
987,351
-
$30.1M0.0%$31.97
40
2025-Q2
Exited
0
-100.0%
$00.0%$15.07
0
2025-Q1
New
364,329
-
$4.5M0.0%$11.71
37

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used